SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
NKTR Drug delivery Company
An SI Board Since September 2005
Posts SubjectMarks Bans Symbol
507 31 0 NKTR
Emcee:  david nordic Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
307seekingalpha.comArthur Radley-5/18/2010
306messages.finance.yahoo.com Interesting post on Yahoo..........Arthur Radley-5/15/2010
305At the moment there is no place to hide in this market. I had errands to run thiArthur Radley-5/14/2010
304I think ASCO will remove the embargo on abstract next week, so we should find ouArthur Radley-5/12/2010
303Phase I data to be presented this July. 2010 ASCO poster session. NKTR-105 is adavid nordic15/12/2010
302The stock is strong today..but moves all over the board with such small volume. Arthur Radley-5/12/2010
3012010 ASCO Phase IIB Ovarian cancer top line 22% Recist (9-13.6% range) waiting fdavid nordic-5/11/2010
300Dave, Sort of lonely here......but I picked up a few shares this morning at $13.Arthur Radley-5/11/2010
299Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Studavid nordic-3/8/2010
298UPDATE 1-Nektar posts prelim data from cancer trial Tue Jan 12, 2010 9:47am ESTdavid nordic-1/12/2010
297Nektar is finally turning around after Exubera failure. NKTR 102 (Pegylated Irindavid nordic-12/7/2009
296Nektar could get up to $1.12B from AstraZeneca NEW YORK (AP) -- Nektar Therapeuzax-9/21/2009
295<B>Cimzia Approved for RA!!!</B> Next stop, the BANK. 9:49AM Nektazax-5/14/2009
294Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patientdavid nordic-3/2/2009
293On February 24, 2009, the company announced that it would hold a conference calldavid nordic-3/2/2009
292NKTR has 5 cancer drugs in trials reporting +.83 EPS 4 drugs in Phase IIB Phasdavid nordic-2/25/2009
291Pegylated Docetaxel Dosing Begins in Phase 1 Clinical Study Evaluating NKTR-105 david nordic-2/17/2009
290Recent data(2) presented at the 2008 American Society of Clinical Oncologists (Atnsaf-6/9/2008
289New Positive Data Announced for NKTR-102 (PEG-irinotecan), Highlights Promise oftnsaf-6/9/2008
288Nektar's Technology Enables First-Ever PEGylation of a Small Molecule with Dtnsaf-5/21/2008
287<b>Bayer's inhaler drug gets thumbs up in test</b> <i>[Daidos-5/20/2008
286<B>Approved: Cimzia for Crohn's disease</B> 8:02AM Nektar Therazax-4/23/2008
285Cimzia approved by the FDA for Crohn's, but with a pretty tough label. One tuck-4/22/2008
284I bougth NKTR as a play on their Remicade competitor drug in the pipeline. Perhzax-4/10/2008
283News today finally kills inhaled insulin as option ...I think the drop in the stArthur Radley-4/9/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News